Trinity Biotech plc
TRIBNASDAQHealthcareMedical Devices
As of Oct 26, 2026 close
- Market cap
- $4.40M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.50$22.50
- Volume (live)
- -
- Avg. volume (3M)
- 13.45K
Trinity Biotech (TRIB) Stock Price & Financial Analysis
Trinity Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $7.11 - $7.50 |
|---|---|
| 52-Week High | $22.50 |
| 52-Week Low | $0.50 |
| Open | $7.30 |
| Volume (last close) | 14.68K |
| Average Volume (3M) | 13.45K |
| Revenue (TTM) | 47.36M |
|---|---|
| Net Income (TTM) | -39.93M |
| Free Cash Flow (TTM) | -4.79M |
| EPS (TTM) | −$64.20 |
| Profit Margin | -84.31% |
| Operating Margin | -19.85% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Last Dividend Ex-Date | Jun 5, 2015 |
| Market Cap | 4.40M |
|---|---|
| Shares Outstanding | 619.20K |
| Price to Sales (P/S) | 0.09 |
| Price to Book (P/B) | -0.06 |
| EV/EBITDA | -26.19 |
| 50-Day MA | $8.44 |
|---|---|
| 200-Day MA | $8.15 |
| 1-Year Change | +693.62% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Trinity Biotech at a Glance
As of the Oct 26, 2026 close, Trinity Biotech (TRIB) has a market capitalization of $4.40M. The stock trades at 0.1× sales. Over the trailing twelve months it lost $39.93M on revenue of $47.36M and burned $4.79M of free cash flow. Revenue fell 12.9% year over year.
As of its latest reported balance sheet, it holds $5.14M in cash and securities against $137.98M of debt, a net debt position of $132.84M.
Trinity Biotech does not currently pay a dividend.
The share price is up 693.6% over the past year. At $7.11 (the Oct 26, 2026 close) it sits within its 52-week range of $0.50 to $22.50, below its 200-day moving average of $8.15.
Frequently Asked Questions About Trinity Biotech
What is the current stock price for TRIB?
As of the Oct 26, 2026 close, TRIB stock trades at $7.11. The 52-week range is $0.50–$22.50, with a day range of $7.11–$7.50.
What is the P/E ratio for TRIB?
The P/E ratio (Price-to-Earnings) for TRIB is shown in the Key Statistics section. This valuation metric helps compare Trinity Biotech plc to industry peers.
Does TRIB pay dividends?
Trinity Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TRIB?
Analyst ratings and recommendations for TRIB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TRIB?
As of the Oct 26, 2026 close, Trinity Biotech's market capitalization is $4.4M, classifying it as a micro-cap company. Trinity Biotech operates in the Healthcare sector within the Medical Devices industry.